Ignite Creation Date:
2025-12-25 @ 1:19 AM
Ignite Modification Date:
2025-12-25 @ 11:28 PM
Study NCT ID:
NCT01252693
Status:
COMPLETED
Last Update Posted:
2021-10-05
First Post:
2010-12-01
Is NOT Gene Therapy:
False
Has Adverse Events:
False
Brief Title:
International,Multi-Center,Open Label,Randomized Study Assessing the Safety and Efficacy of a Monthly Dosing Regimen of Ozarelix Versus Goserelin Depot in Men With Prostate Cancer
Sponsor:
Spectrum Pharmaceuticals, Inc
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2010-11
Start Date Type:
ACTUAL
Primary Completion Date:
2014-09
Primary Completion Date Type:
ACTUAL
Completion Date:
2015-05
Completion Date Type:
ACTUAL
First Submit Date:
2010-12-01
First Submit QC Date:
None
Study First Post Date:
2010-12-03
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
2021-10-05
Disp First Post Date Type:
ACTUAL
Last Update Submit Date:
2021-09-30
Last Update Post Date:
2021-10-05
Last Update Post Date Type:
ACTUAL